Deep Vein Thrombosis Market Projected to Ascend to $1.26 billion by 2028: A Fresh Global Market Report Unveiled
January 29, 2024 18:55 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Deep Vein Thrombosis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. An extensive global market report on...
Acquired Orphan Blood Disease Market Research Reveals Rapid Growth in Asia and Innovative Therapies
January 25, 2024 05:39 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Acquired Orphan Blood Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Thrombosis And Hemostasis Biomarkers Research Report 2023: Point-of-Care Analyzers Gain Traction - Global Forecast to 2030
November 22, 2023 07:18 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test...
Vascular Closure Device Market Share Worth $2.80 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 08, 2023 08:53 ET
|
The Insight Partners
Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed...
Anthos Therapeutics Supported Global Survey of 3000+ Patients Prescribed Anticoagulants Detailing Impact of Patient-Relevant Bleeding (PRB) Presented at ISTH 2023
June 26, 2023 07:00 ET
|
Anthos Therapeutics
Patient-Centric Survey Conducted in Collaborationwith StopAfib.org and the National Blood Clot Alliance Findings Suggest “Patient-Relevant Bleeding” More Accurate Than Current Terminology,...
Bare-metal Stents Market to Achieve Remarkable Growth, Projected at 5.2% CAGR, and Surpassing USD 4.8 Billion by 2031 – TMR Study
May 24, 2023 04:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 24, 2023 (GLOBE NEWSWIRE) -- The global bare metal stents market is projected to flourish at a CAGR of 5.2% from 2023 to 2031. As per the report published by...
New Assessment Scale to Measure Adherence to Oral Anticoagulants Based on Impact of Patient Relevant Bleeding in Atrial Fibrillation Presented at ISPOR 2023
May 09, 2023 09:45 ET
|
Anthos Therapeutics
Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale [ABBA-CAS] Created to Better Address an Important Treatment Gap in the Management of Atrial Fibrillation (AF) and Bring Patient...
New Assessment Scale to Capture Patient Relevant Bleeding to be Presented at ISPOR 2023
May 05, 2023 08:00 ET
|
Anthos Therapeutics
Additional presentation spotlights GARDENIA registry design in patientswith atrial fibrillation and atrial flutter Early Cost-Effectiveness Modeling for Patients with Atrial Fibrillation and Cancer...
Aronora CEO Named National Academy of Inventors Fellow
December 08, 2022 10:00 ET
|
Aronora, Inc
PORTLAND, Ore., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Erik Tucker, Ph.D., joins an elite group of inventors with his election to the National Academy of Inventors. Dr. Tucker's research into blood...
Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
December 06, 2022 07:00 ET
|
Aronora, Inc
PORTLAND, Ore., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that...